Bayer to Present 7 New Analyses on Finerenone’s Benefits in High-Risk Heart Failure Patients

Bayer has announced new subgroup analyses from the Phase III FINEARTS-HF trial, which evaluated the efficacy of finerenone (Kerendia™) in patients with heart failure (HF) with a left ventricular ejection fraction (LVEF) of 40% or higher. These findings will be…

Read MoreBayer to Present 7 New Analyses on Finerenone’s Benefits in High-Risk Heart Failure Patients

Brenntag Specialties Signs U.S. Distribution Deal with Capsoil Technologies

Brenntag, the global leader in chemicals and ingredients distribution, has announced a new distribution agreement in the U.S. with Capsoil Technologies, an Israeli tech company that specializes in converting lipophilic and hydrophilic active ingredients into water-soluble powders through advanced patented…

Read MoreBrenntag Specialties Signs U.S. Distribution Deal with Capsoil Technologies

Bayer Co.Lab Shanghai Launches in Global Life Science Incubator Expansion

Bayer has officially opened its new life science incubator, Bayer Co.Lab Shanghai, located in the Shanghai Innovation (SH-INNO) Park within China’s largest biopharma hub, Zhangjiang, Shanghai. This marks a significant step in Bayer’s global innovation strategy, with Co.Lab Shanghai joining…

Read MoreBayer Co.Lab Shanghai Launches in Global Life Science Incubator Expansion